‘A Game Changer’: Drug Brings Weight Loss in Patients with Obesity

Interesting results. It says that for the participants in the trial on the drug, the weight began to come back after they stopped taking the drug. This might be a block buster drug for Novo Nordisk at $12k/year/pp. The numbers are astounding.